Department of Justice
DOJ v. Justin Bradley Watkins
Pending
Justin Bradley Watkins allegedly received, recommended, delivered, and sold to his unwitting patients, misbranded drugs from China that were not approved by the United States Food and Drug Administration (FDA). According to the allegations in court documents, Watkins obtained misbranded drugs from China, specifically peptides that he knew were not FDA approved. Watkins is charged with receipt in interstate commerce and delivery for pay misbranded drugs with intent to defraud or mislead, and aiding and abetting.
Summary generated from official Department of Justice press release
Source: Department of Justice Press Release ↗Case Details
Industry
Healthcare